Literature DB >> 22867094

Lifestyle-related risk factors, smoking status and cardiovascular disease.

Renata Giudice1, Raffaele Izzo, Maria Virgina Manzi, Giampiero Pagnano, Mario Santoro, Maria Assunta Elena Rao, Gianfranco Di Renzo, Nicola De Luca, Valentina Trimarco.   

Abstract

BACKGROUND: Cardiovascular disease represents one of the most important causes of morbidity and mortality in highly developed countries and is known to be associated with some lifestyle-related risk factors (e.g. alcohol consumption, smoking status, diet, physical activity, bodyweight). There is still incomplete information about their combined effect on cardiovascular risk in hypertensive patients with optimal pharmacological blood pressure control. AIM: The objective of this study was to evaluate the correlation of some lifestyle behaviours, using a specific questionnaire, with development of cardiovascular disease in treated hypertensive patients.
METHODS: 617 hypertensive, non-diabetic participants (aged 53.1 ± 7.6 years, 44.9% male; mean age 53.1 ± 7.6 years) free of prevalent cardiovascular disease, cancer, liver cirrhosis and/or failure, chronic kidney disease more than grade 3 (glomerular filtration rate by the Modification of Diet in Renal Disease study <30 mL/min/1.73 m2) were analysed. Metabolic syndrome was defined according to the Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Left ventricular hypertrophy was defined when left ventricular mass index was >51 g/m2. Carotid artery atherosclerosis was assessed as an increased intima medial thickness (IMT) by B-mode ultrasonography. IMT values between 0.9 and 1.3 mm were defined as 'thickening' and those >1.3 mm as 'plaque'. Assessment of smoking status, dietary and non-dietary factors was established by administration of a specific questionnaire.
RESULTS: In the initial population of examined patients, 288 were smokers and 329 were non-smokers. At baseline, the patients belonging to smoking group were less often overweight than those belonging to the non-smoking group, showing a lower initial body mass index (BMI) [27.54 ± 4.0 vs 28.28 ± 4.3; p < 0.029], lower plasma levels of high-density lipoprotein cholesterol (HDL-C) [48.14 ± 12.6 vs 51.39 ± 14.1 mg/dL; p < 0.006] and were more often affected by carotid artery atherosclerosis (93.9 % vs 86.1%; p < 0.002) than non-smoking patients. When analysed for dietary and other lifestyle-related risk factors, we found a higher prevalence of carotid atherosclerotic disease in patients consuming less than two meals per day than in those consuming more than two meals per day (96.6% vs 85.7%; p < 0.001), without any significant difference in the mean number of medications taken and in specific classes of medications. Total amount of cigarettes smoked, calculated as packs per year (39.14 ± 16.5 vs 20.81 ± 13.6; p < 0.0001) was higher in patients with a diagnosis of atherosclerotic disease of the carotid artery than in patients free of this disorder, whereas the average age at which people began smoking was lower (17.58 ± 6.3 vs 21.53 ± 10.2 years). In a binary model of logistic regression adjusted for BMI, HDL-C, smoking status and number of daily meals, only smoking status was confirmed to be strongly correlated to clinical evidence of carotid atherosclerosis (p < 0.025).
CONCLUSIONS: In hypertensive patients, in optimal blood pressure control, smoking status has been shown to be independently associated with an increased maximum arterial IMT (IMTmax). In particular, an increase of the IMT was associated with the total amount of cigarettes smoked (calculated as packs per year) and the average age at which people began smoking.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22867094     DOI: 10.1007/bf03262458

Source DB:  PubMed          Journal:  High Blood Press Cardiovasc Prev        ISSN: 1120-9879


  31 in total

1.  A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women.

Authors:  S Liu; W C Willett; M J Stampfer; F B Hu; M Franz; L Sampson; C H Hennekens; J E Manson
Journal:  Am J Clin Nutr       Date:  2000-06       Impact factor: 7.045

2.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.

Authors:  Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart
Journal:  J Am Soc Echocardiogr       Date:  2005-12       Impact factor: 5.251

3.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

Authors:  R B Devereux; D R Alonso; E M Lutas; G J Gottlieb; E Campo; I Sachs; N Reichek
Journal:  Am J Cardiol       Date:  1986-02-15       Impact factor: 2.778

4.  Increased meal frequency associated with decreased cholesterol concentrations; Rancho Bernardo, CA, 1984-1987.

Authors:  S L Edelstein; E L Barrett-Connor; D L Wingard; B A Cohn
Journal:  Am J Clin Nutr       Date:  1992-03       Impact factor: 7.045

5.  Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study.

Authors:  Martin J O'Donnell; Denis Xavier; Lisheng Liu; Hongye Zhang; Siu Lim Chin; Purnima Rao-Melacini; Sumathy Rangarajan; Shofiqul Islam; Prem Pais; Matthew J McQueen; Charles Mondo; Albertino Damasceno; Patricio Lopez-Jaramillo; Graeme J Hankey; Antonio L Dans; Khalid Yusoff; Thomas Truelsen; Hans-Christoph Diener; Ralph L Sacco; Danuta Ryglewicz; Anna Czlonkowska; Christian Weimar; Xingyu Wang; Salim Yusuf
Journal:  Lancet       Date:  2010-06-17       Impact factor: 79.321

6.  Smoking cessation in relation to total mortality rates in women. A prospective cohort study.

Authors:  I Kawachi; G A Colditz; M J Stampfer; W C Willett; J E Manson; B Rosner; D J Hunter; C H Hennekens; F E Speizer
Journal:  Ann Intern Med       Date:  1993-11-15       Impact factor: 25.391

7.  Dietary fat intake and the risk of coronary heart disease in women.

Authors:  F B Hu; M J Stampfer; J E Manson; E Rimm; G A Colditz; B A Rosner; C H Hennekens; W C Willett
Journal:  N Engl J Med       Date:  1997-11-20       Impact factor: 91.245

8.  Smoking selectively accelerates carotid atherosclerosis in hypertensive patients.

Authors:  Raffaele Izzo; Gianfranco Di Renzo; Nicola De Luca; Valentina Trimarco; Francesco Buono; Salvatore Crispo; Renata Giudice; Frazer Lowe; Mike McEwan; Francesco Rozza; Antonella Bassi; Alfredo Nunziata; Lucio Annunziato; Bruno Trimarco
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-01-22

9.  Carotid intima-media thickness in confirmed prehypertensive subjects: predictors and progression.

Authors:  Romana Femia; Michaela Kozakova; Monica Nannipieri; Clicerio Gonzales-Villalpando; Michael P Stern; Steven M Haffner; Ele Ferrannini
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-07-26       Impact factor: 8.311

10.  Insufficient control of blood pressure and incident diabetes.

Authors:  Raffaele Izzo; Giovanni de Simone; Marcello Chinali; Guido Iaccarino; Valentina Trimarco; Francesco Rozza; Renata Giudice; Bruno Trimarco; Nicola De Luca
Journal:  Diabetes Care       Date:  2009-02-17       Impact factor: 19.112

View more
  8 in total

Review 1.  Nutraceuticals: Definition and Epidemiological Rationale for Their Use in Clinical Practice.

Authors:  Roberto Volpe; Gianluca Sotis
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-05-01

Review 2.  Prevention of coronary artery disease: recent advances in the management of hypertension.

Authors:  Chiara Recarti; Thomas Unger
Journal:  Curr Atheroscler Rep       Date:  2013-03       Impact factor: 5.113

Review 3.  Assessment of potential cardiovascular risks of methylphenidate in comparison with sibutramine: do we need a SCOUT (trial)?

Authors:  Jochen Antel; Özgür Albayrak; Gerd Heusch; Tobias Banaschewski; Johannes Hebebrand
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-08-23       Impact factor: 5.270

4.  Clustering of risk factors with smoking habits among adults, Sousse, Tunisia.

Authors:  Jihene Maatoug; Imed Harrabi; Sonia Hmad; Mylene Belkacem; Mustafa Al'absi; Harry Lando; Hassen Ghannem
Journal:  Prev Chronic Dis       Date:  2013-12-19       Impact factor: 2.830

5.  Clustering of Risk Behaviors and their Social Determinants among Primary School Learners in Beijing, China: A Cross-sectional Study.

Authors:  Yan Zhang; Ying Ji
Journal:  Chin Med J (Engl)       Date:  2015-06-20       Impact factor: 2.628

Review 6.  Pharmacological Approach to Smoking Cessation: An Updated Review for Daily Clinical Practice.

Authors:  Federico Giulietti; Andrea Filipponi; Giulia Rosettani; Piero Giordano; Corrado Iacoacci; Francesco Spannella; Riccardo Sarzani
Journal:  High Blood Press Cardiovasc Prev       Date:  2020-06-23

7.  Smoker's characteristics, general health and their perception of smoking in the social environment: a study of smokers in Rajshahi City, Bangladesh.

Authors:  Md Kamruzzaman; Ahammad Hossain; Enamul Kabir
Journal:  Z Gesundh Wiss       Date:  2021-01-06

8.  Incidental findings detected with panoramic radiography: prevalence calculated on a sample of 2017 cases treated at a major Italian trauma and cancer centre.

Authors:  Sogol Ghassemzadeh; Luca Sbricoli; Anna Chiara Frigo; Christian Bacci
Journal:  Oral Radiol       Date:  2020-11-19       Impact factor: 1.852

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.